Constance, C., Ben-Yehuda, O., Wenger, N. K., Zieve, F., Lin, J., Hanson, M. E., . . . Tershakovec, A. M. (2014). Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: Attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years. BioMed Central.

Constance, Christian, Ori Ben-Yehuda, Nanette K. Wenger, Franklin Zieve, Jianxin Lin, Mary E. Hanson, Robert S. Lowe, and Andrew M. Tershakovec. Atorvastatin 10 mg Plus Ezetimibe Versus Titration to Atorvastatin 40 mg: Attainment of European and Canadian Guideline Lipid Targets in High-risk Subjects ≥65 years. BioMed Central, 2014.

Constance, Christian, et al. Atorvastatin 10 mg Plus Ezetimibe Versus Titration to Atorvastatin 40 mg: Attainment of European and Canadian Guideline Lipid Targets in High-risk Subjects ≥65 years. BioMed Central, 2014.